Read about the latest breakthroughs, awards and ongoing work from the SGC. Discover how our work is making a global impact and driving forward the field of drug discovery. Interested in getting first the latest news from SGC?
The Structural Genomics Consortium (SGC) is pleased to announce that Dr. Rachel Harding, Principal Investigator at SGC-Toronto, has been awarded a Canadian Institutes of Health Research (CIHR) Fall 2024 Project Grant for her research project, "Macrocyclic Peptides to Uncover Huntington Disease…
Tags: Award
Photo left to right: Johannes Dopfer (SGC-Frankfurt) and Jacob Capener (SGC-UNC).
For over two decades, the Structural Genomics Consortium (SGC) has not only established itself as a global leader in accelerating early drug discovery but has also served as an incubator…
As the Structural Genomics Consortium (SGC) enters its third decade, it is embarking on an ambitious goal: to become the world’s largest generator of open-source protein-ligand data. Recognizing the growing importance of data science in early-stage drug discovery, SGC…
Categories